What is Windlas Biotech Ltd. Quarterly Revenue?

Windlas Biotech Ltd. Quarterly Revenue Windlas Biotech Jun-2026 Quarterly Revenue is Rs 253 Cr which is growth of 17.6% YoY.

What is Windlas Biotech Ltd. Quarterly Net Profit?

Windlas Biotech Ltd. Quarterly Net Profit Windlas Biotech Jun-2026 Quarterly Net Profit is Rs 18 Cr which is growth of -0.1% YoY.

What is Windlas Biotech Ltd. Annual Revenue?

Windlas Biotech Ltd. Annual Revenue Windlas Biotech Mar-2026 Annual Revenue is Rs 922 Cr which is growth of 18.6% YoY.

What is Windlas Biotech Ltd. Annual Net Profit?

Windlas Biotech Ltd. Annual Net Profit Windlas Biotech Mar-2026 Annual Net Profit is Rs 66 Cr which is growth of 9.5% YoY.

What is Windlas Biotech Ltd. Total Shareholders Fund?

Windlas Biotech Ltd. Total Shareholders Fund Windlas Biotech Mar-2026 Total Shareholders Fund is Rs 581 Cr which is growth of 14.8% YoY.

What is Windlas Biotech Ltd. Total Assets?

Windlas Biotech Ltd. Total Assets Windlas Biotech Mar-2026 Total Assets is Rs 907 Cr which is growth of 19.3% YoY.

What is Windlas Biotech Ltd. Book Value Per Share?

Windlas Biotech Ltd. Book Value Per Share Windlas Biotech Mar-2026 Book Value Per Share is 275 Rs which is growth of 14.0% YoY.

What is Windlas Biotech Ltd. ROE?

Windlas Biotech Ltd. ROE Windlas Biotech Mar-2026 ROE is 11% which is growth of 0.6% YoY.

What is Windlas Biotech Ltd. Cash From Operating Activity?

Windlas Biotech Ltd. Cash From Operating Activity Windlas Biotech Mar-2026 Cash From Operating Activity is Rs 105 Cr which is growth of 53.8% YoY.

What is Windlas Biotech Ltd. Net Cash Flow?

Windlas Biotech Ltd. Net Cash Flow Windlas Biotech Mar-2026 Net Cash Flow is Rs 0 Cr which is growth of 102.2% YoY.

Windlas Biotech Ltd.

NSE: WINDLAS | BSE: 543329

Mid-range Performer

Download real time

US FDA Inspections ANDA Approvals

33.55(3.83%)

30.43% Gain from 52W Low

71,013

NSE+BSE Volume

NSE 02 Nov, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Board Meeting

The next board meeting for Windlas Biotech is on 05 Nov 2026 for the purpose of Quarterly Results See details

Windlas Biotech quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Windlas Biotech quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Windlas Biotech Jun-2026 Quarterly Revenue is Rs 253 Cr which is growth of 17.6% YoY.
NEGATIVE
Quarterly Net Profit Windlas Biotech Jun-2026 Quarterly Net Profit is Rs 18 Cr which is growth of -0.1% YoY.

Windlas Biotech Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	253.2	242.9	237.6	226	215.3	207.7	198.8	191.8	179.3	175.7	165.4	155.9	147.4
SR_Q Operating Rev.	248.1	238.5	233.1	222.4	210.1	202.7	195	187	175.2	171.3	162.2	152.7	144.8
OI_Q Other Income	5.1	4.4	4.5	3.6	5.2	4.9	3.7	4.8	4.1	4.4	3.2	3.2	2.6
OEXPNS_Q Operating Exp.	221.4	213.3	208.7	193.8	183.6	177.2	170.4	164	154.3	149.4	141.9	134	127.6
OEXPNS_Q Operating Exp.	221.4	213.3	208.7	193.8	183.6	177.2	170.4	164	154.3	149.4	141.9	134	127.6
OP_Q Operating Profit	26.7	25.2	24.4	28.6	26.5	25.6	24.6	23.1	20.9	21.9	20.3	18.7	17.1
OPMPCT_Q Operating Profit Margin %	10.75%	10.58%	10.46%	12.84%	12.63%	12.60%	12.63%	12.33%	11.92%	12.81%	12.54%	12.24%	11.84%
DEP_Q Depr.	7.2	8	7.7	7.6	7.5	8.3	6.9	6.5	6.2	3.5	3.4	3.3	3.2
INT_Q Interest	1.7	1.5	1.3	1	1.1	1.3	1.5	1.1	0.5	0.3	0.3	0.3	0.2
PBT_Q Profit Before Tax	22.9	20.2	19.9	23.6	23.3	20.8	20	20.3	18.3	22.6	19.8	18.3	16.3
TAX_Q Tax	5.3	4.2	5	5.8	5.6	4.5	4.7	4.6	4.8	5.6	4.7	4.3	4.3
NP_Q Net Profit	17.7	16	15	17.8	17.7	16.3	15.2	15.7	13.5	17	15.1	14	12.1
EPS_adj_Q EPS Adj. latest	8.4	7.6	7.1	8.5	8.4	7.8	7.3	7.5	6.4	8.1	7.2	6.7	5.8
NP_TTM Net profit TTM	66.4	66.4	66.7	67	64.8	60.7	61.3	61.2	59.6	58.1	52.6	46.7	44.9
EPS_TTM Basic EPS TTM	32.2	31.5	31.7	31.8	30.9	28.9	29.3	29.3	28.5	28	25.3	22.5	21.6
earnings_transcripts Earnings Transcripts
ai_summary AI Summary
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes		Notes	Notes	Notes		Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Windlas Biotech competitor comparison and performance snapshot within industry

Windlas Biotech annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Windlas Biotech Mar-2026 Annual Revenue is Rs 922 Cr which is growth of 18.6% YoY.
POSITIVE
Annual Net Profit Windlas Biotech Mar-2026 Annual Net Profit is Rs 66 Cr which is growth of 9.5% YoY.

Windlas Biotech Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19
SR_A Total Rev. Ann. ⌄	20.8%	16.4%	959.8	921.9	777.5	644.4	523.1	472.6	430.7	329.8	290.3
TotalOperatingRevenues_A Operating Rev. Ann.	20.8%	16.2%	942.1	904.1	759.9	631	513.1	465.9	427.6	328.9	288.2
OI_A Other Income Ann.	21.2%	41.8%	17.7	17.8	17.7	13.5	10	6.7	3.1	1	2.1
OEXPNS_A Operating Exp. Ann.	20.9%	16.5%	837.2	799.4	665.8	552.9	452.8	413	372.9	288.2	243.7
OEXPNS_A Operating Exp. Ann.	20.9%	16.5%	837.2	799.4	665.8	552.9	452.8	413	372.9	288.2	243.7
OP_A Operating Profit Ann.	20.3%	13.9%	104.9	104.7	94.1	78.1	60.2	52.9	54.7	40.7	44.5
OPMPCT_A OPM Ann. %	-0.5%	-2.2%		11.36%	12.10%	12.12%	11.52%	11.19%	12.70%	12.33%	15.32%
TotalExpenses_A Total Exp. Ann. ⌄	21.5%	16.6%		835	698.1	567.4	466	426.6	387.2	299.2	255.5
OtherExpenses_A Other Exp. Ann.	16.4%	17.5%	92.7	90.1	71	69.2	57.1	46.8	40.2	32.7	29
EmployeeBenefitExpenses_A Employee Exp. Ann.	29.3%	21.1%	164.3	152.1	122.9	87.5	70.3	63.4	58.3	43.9	33.5
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	20.4%	16.2%		122.5	111.8	91.6	70.2	59.6	57.8	41.6	46.6
EBIDTPCT_A EBITDA Ann. margin %	-0.3%	-0.2%		13.29%	14.37%	14.21%	13.42%	12.61%	13.42%	12.62%	16.05%
INT_A Interest Ann.	81.7%	29.9%	5.4	4.8	4.4	1.1	0.8	1.4	1.3	2.4	3.6
DEP_A Depr.	35.3%	18.8%	30.5	30.7	28	13.4	12.4	12.2	13	8.7	8.1
PBT_A PBT Ann.	15%	50.6%	86.6	86.9	79.4	77	57.1	46	11.2	30.6	34.9
TAX_A Tax Ann.	12.5%	27%	20.2	20.5	18.7	18.9	14.4	7.5	6.2	8.1	12.4
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	15.9%	67.7%		66.4	60.7	58.1	42.6	38.6	5	22.5	22.5
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	15.9%	67.7%	66.4	66.4	60.7	58.1	42.6	38.6	5	22.5	22.5
NETPCT_A NPM Ann. %	-4.1%	44.4%		7.34%	7.98%	9.21%	8.31%	8.27%	1.17%	6.82%	7.79%
EPS_adj_A EPS Adj. latest Ann.	16%	67.6%		31.7	28.9	27.7	20.3	18.4	2.4	10.7	10.7
result_notes Result Notes				Notes			Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

18.6%

2Y CAGR

19.6%

3Y CAGR

20.8%

5Y CAGR

16.4%

7Y CAGR

17.9%

Total Revenue Annual growth is stable compared to historical averages.

Net Profit Ann.

1Y CHG

9.4%

2Y CAGR

6.9%

3Y CAGR

15.9%

5Y CAGR

67.7%

7Y CAGR

16.7%

Net Profit Annual growth is lower than historical averages.

Operating Exp. Ann.

1Y CHG

20.1%

2Y CAGR

20.2%

3Y CAGR

20.9%

5Y CAGR

16.5%

7Y CAGR

18.5%

Operating Expenses Annual Cr growth is stable compared to historical averages.

Windlas Biotech balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Windlas Biotech Mar-2026 Total Shareholders Fund is Rs 581 Cr which is growth of 14.8% YoY.
POSITIVE
Total Assets Windlas Biotech Mar-2026 Total Assets is Rs 907 Cr which is growth of 19.3% YoY.

Windlas Biotech Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	13%	23.9%	580.8	505.8	450.3	402.7	395.1	199	216.5	194
EQCAP_A Equity Share Capital Ann.	0.3%	10.6%	10.6	10.5	10.4	10.5	10.9	6.4	6.4	6.4
TotalShareCapital_A Total Share Capital Ann.	0.3%	10.6%	10.6	10.5	10.4	10.5	10.9	6.4	6.4	6.4
ReservesAndSurplus_A Reserves Plus Surplus Ann.	13.3%	24.2%	570.3	495.3	439.9	392.2	384.2	192.6	210.1	187.6
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	13.3%	24.2%	570.3	495.3	439.9	392.2	384.2	192.6	210.1	187.6
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	0.6%	9.2%	5.6	5.2	4.5	5.5	2.3	3.6	2.4	6.9
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	-	-						0.7
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-11.3%	26.9%	2.3	2.4	2.2	3.3	0.2	0.7
CL_A Total Current Liabilities Ann. ⌄	38.5%	28%	320.9	249.4	171.4	120.9	93.7	93.4	124.9	96.1
TradePayables_A Trade Payables Ann.	39.7%	43%	238.5	167.2	131.1	87.4	62.9	39.9	83.1	57.9
OtherCurrentLiabilities_A Other Current Liabilities Ann.	15.8%	16.4%	50.8	53.5	39.4	32.7	24.8	23.8	20.4	16.5
ShortTermProvisions_A ST Provisions Ann.	53.3%	43.1%	1.8	1.6	0.7	0.5	0.3	0.3	0.4	4.6
TL_A Total Capital Plus Liabilities Ann.	19.7%	25.1%	907.3	760.5	626.2	529	491	296	343.8	297
FixedAssets_A Fixed Assets Ann. ⌄	30%	23.2%	272.9	228.7	184.8	124.2	99.2	96	68.4	66.5
TangibleAssets_A Tangible Assets Ann.	24.4%	17.1%	209.9	218.7	174.6	108.9	90.7	95.5	67.9	61.5
IntangibleAssets_A Intangible Assets Ann.	91.3%	47.6%	3.5	4.7	4.5	0.5	0.5	0.5	0.6	0.4
CapitalWorkInProgress_A Capital Work In Progress Ann.	59.7%	-	56.2	3.2	5.7	13.8	7.6	0		4.6
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	16.9%	22.5%	280.5	235.3	194.9	175.5	109.4	101.8	181.1	180.6
NonCurrentInvestments_A Non Current Investments Ann.	-	-				0	0	0	104.7	104.7
DeferredTaxAssets_A Deferred Tax Assets Ann.	-37%	-	0.5	0.3	0.6	2	2		2	1.8
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-						3	5.9	7.4
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-47.5%	19.6%	7.1	6.3	9.6	49.2	8.1	2.9	0.1	0.2
CA_A Total Current Assets Ann. ⌄	21%	26.4%	626.8	525.1	431.2	353.5	381.6	194.2	162.7	116.4
CurrentInvestments_A Current Investments Ann.	36.1%	63.3%	268.4	223.4	173.4	106.5	64.8	23.1	16.3	16.3
TradeReceivables_A Trade Receivables Ann.	24.8%	23.4%	227.4	166.9	136.3	116.9	110.8	79.4	64.6	62.3
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-58.7%	-43.4%	1.8	15.9	30.9	25.5	113.8	31	18.4	13.2
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-	-							14.1	5.6
OtherCurrentAssets_A Other Current Assets Ann.	31%	28.5%	67.4	37.6	28.4	30	33.5	19.2	0.1	0.1
TA_A Total Assets Ann.	19.7%	25.1%	907.3	760.5	626.2	529	491	296	343.8	297
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-37.2%	-	3.5	2.1	15.3	14.1	3.3			0.3
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	0%	-	2.7	2.7	2.7	2.7	2.7
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-	-				0	0	0	104.7	104.7
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-					64.8

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

19.3%

2Y CAGR

20.4%

3Y CAGR

19.7%

5Y CAGR

25.1%

7Y CAGR

17.3%

Total Assets Annual growth is stable compared to historical averages.

Total Current Liabilities Ann.

1Y CHG

28.7%

2Y CAGR

36.8%

3Y CAGR

38.5%

5Y CAGR

28%

7Y CAGR

18.8%

Total Current Liabilities Annual Cr growth is stable compared to historical averages.

Total ShareHolders Funds Ann.

1Y CHG

14.8%

2Y CAGR

13.6%

3Y CAGR

13%

5Y CAGR

23.9%

7Y CAGR

17%

Total ShareHolders Funds Annual growth is stable compared to historical averages.

Windlas Biotech ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Windlas Biotech Mar-2026 Book Value Per Share is 275 Rs which is growth of 14.0% YoY.
POSITIVE
ROE Windlas Biotech Mar-2026 ROE is 11% which is growth of 0.6% YoY.

Windlas Biotech Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19
BVSH_A BVSH Ann.	12.7%	-2.4%	275.2	241.3	216.5	192.4	181.3	310.4	337.7	302.6
ROA_A RoA Ann. %	-3.2%	34.1%	7.32%	7.97%	9.28%	8.06%	7.85%	1.69%	6.53%	7.56%
ROE_A ROE Ann. %	2.6%	35.4%	11.43%	11.99%	12.91%	10.59%	9.75%	2.51%	10.37%	11.58%
ROCE_A ROCE Ann. %	3.3%	-6.7%	15.64%	16.39%	17.17%	14.17%	11.94%	22.12%	15.05%	19.16%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	-0.3%	0%	13.54%	14.70%	14.51%	13.68%	12.79%	13.51%	12.65%	16.16%
PBITMargin_A EBIT Ann. Margin %	-3.5%	-0.7%	10.14%	11.02%	12.38%	11.27%	10.18%	10.48%	10.01%	13.35%
PBTMargin_A PBT Ann. Margin %	-4.7%	29.8%	9.61%	10.44%	12.20%	11.12%	9.88%	2.61%	9.29%	12.09%
NETPCT_A NPM Ann. %	-4.1%	44.4%	7.34%	7.98%	9.21%	8.31%	8.27%	1.17%	6.82%	7.79%
ASETTO_A Asset Turnover Ann. %	3.2%	-3.3%	1.1	1.1	1.1	1	1.2	1.3	1	-
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	-11.6%	-1%	2	2.1	2.5	2.9	4.1	2.1	1.3	1.2
QuickRatio_A Quick Ratio Ann.	-7.8%	2.4%	1.8	1.8	2.2	2.3	3.5	1.6	0.9	1
DividendPayoutNP_A Dividend Payout to NP Ann.	0%	-	0.2	0.2	0.1	0.2			-	-
EarningRetention_A Earning Retention Ann. %	-0.2%	-	81.71%	81.05%	85.70%	82.12%	80.23%
CashEarningRetention_A Cash Earning Retention Ann. %	0.5%	-	87.50%	87.04%	88.38%	86.14%	84.96%
CashEarningRetention_A Cash Earning Retention Ann. %	0.5%	-	87.50%	87.04%	88.38%	86.14%	84.96%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	52.6%	-	1,585	2,193.6	1,034.8	446.2	350.2
EVPerNetSales_A EV Per Net Sales Ann.	26%	-	1.8	2.9	1.6	0.9	0.8	-	-	-
PBV_A Price To Book Value Adjusted	-11.4%	-10.9%	3.29	4.04	4.2	4.73	5.02	5.86	2.69	3.01
EVPerEBITDA_A EV Per EBITDA Ann.	26.3%	-	12.9	19.6	11.3	6.4	5.9	-	-	-
MarketCapPerSales_A Market Cap Per Sales Ann.	23.6%	-	1.7	2.9	1.7	0.9	1	-	-	-
RetentionRatios_A Retention Ratio Ann. %	-0.2%	-	81.70%	81.04%	85.69%	82.11%	80.22%
EYield_A Earnings Yield Ann.	-	-	0	0	0.1	0.1	0.1
DEBT_CE_A Total Debt to Total Equity Ann.			0.1	0.1			0	0.2	0.1	0.1

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

-4.7%

2Y CAGR

-5.9%

3Y CAGR

2.6%

5Y CAGR

35.4%

7Y CAGR

-0.2%

ROE Annual % is falling faster than historical averages.

RoA Ann. %

1Y CHG

-8.2%

2Y CAGR

-11.2%

3Y CAGR

-3.2%

5Y CAGR

34.1%

7Y CAGR

-0.5%

RoA Annual % is falling faster than historical averages.

Current Ratio Ann.

1Y CHG

-4.8%

2Y CAGR

-10.6%

3Y CAGR

-11.6%

5Y CAGR

-1%

7Y CAGR

7.6%

Current Ratio Annual is falling faster than historical averages.

Windlas Biotech cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Windlas Biotech Mar-2026 Cash From Operating Activity is Rs 105 Cr which is growth of 53.8% YoY.
POSITIVE
Net Cash Flow Windlas Biotech Mar-2026 Net Cash Flow is Rs 0 Cr which is growth of 102.2% YoY.

Windlas Biotech Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19
CFO_A Cash from Operating Act. Ann. ⌄	19.8%	55.6%	104.9	68.2	108.9	61	9	11.5	20.9	22.1
PBT_A PBT Ann.	15%	50.6%	86.9	79.4	77	57.1	46	11.2	30.6	34.9
INT_A Interest Ann.	81.7%	29.9%	4.8	4.4	1.1	0.8	1.4	1.3	2.4	3.6
TAX_A Tax Ann.	12.5%	27%	20.5	18.7	18.9	14.4	7.5	6.2	8.1	12.4
CFI_A Cash from Investing Act. Ann.	-	-	-91.8	-74.1	-92.1	-14.1	-154.3	-20.2	-9.2	-6.6
CFA_A Cash from Financing Act. Ann.	-	-	-13	1	-15.3	-43.7	130.1	0.8	-6.5	-8.2
NCF_A Net Cash Flow Ann. ⌄	-68.2%	-	0.1	-4.8	1.6	3.1	-15.2	-8	5.2	7.3
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-12.6%	-53.3%	0.4	5.2	3.7	0.6	15.8	18.1	12.9	5.5
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-48.7%	-49.9%	0.5	0.4	5.2	3.7	0.6	15.8	18.1	12.9

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

53.8%

2Y CAGR

-1.9%

3Y CAGR

19.8%

5Y CAGR

55.6%

7Y CAGR

24.9%

Cash from Operating Activity Annual growth is stable compared to historical averages.

Windlas Biotech investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

Windlas Biotech quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents